Ani Pharmaceuticals (ANIP) Change in Inventory (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Change in Inventory of $437000.0 for Q1 2026, up 111.71% sequentially from -$3.7 million in Q4 2025, and down 30.08% YoY from $625000.0 in Q1 2025.
Ani Pharmaceuticals (ANIP) Change in Inventory (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Change in Inventory for 15 years, with the latest figure at $437000.0 in Q1 2026.
- Quarterly Change in Inventory fell 30.08% year-over-year to $437000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 70.04% YoY) and the FY2025 annual result came in at $6.0 million, down 72.0% from the prior year.
- Change in Inventory advanced to $437000.0 in Q1 2026 per ANIP's latest filing, from -$3.7 million in the prior quarter.
- Over five years, Change in Inventory peaked at $11.6 million in Q2 2024 and troughed at -$3.7 million in Q4 2025.
- A 5-year average of $3.4 million and a median of $2.3 million in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory jumped 1635.58% in 2024, then plunged 652.89% in 2025.
- Over 5 years, Change in Inventory stood at $9.5 million in 2022, then sank by 51.33% to $4.6 million in 2023, then plunged by 85.34% to $675000.0 in 2024, then slumped by 652.89% to -$3.7 million in 2025, then surged by 111.71% to $437000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $437000.0, -$3.7 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | -305,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -305,000.00 |
| Jun 30, 2026 | -305,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Dec 31, 2025 | -3.73 Mn |
| Dec 31, 2025 | -3.73 Mn |
| Sep 30, 2025 | 8.16 Mn |
| Sep 30, 2025 | 8.16 Mn |
| Jun 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 908,000.00 |
| Mar 31, 2025 | 625,000.00 |
| Mar 31, 2025 | 625,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 11.61 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.64 Mn |